RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 156 filers reported holding RELAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,668,054 | -33.0% | 673,966 | 0.0% | 0.15% | -24.4% |
| Q2 2023 | $8,465,013 | -23.7% | 673,966 | 0.0% | 0.20% | -24.2% |
| Q1 2023 | $11,100,220 | +10.2% | 673,966 | 0.0% | 0.26% | +9.5% |
| Q4 2022 | $10,069,052 | -27.2% | 673,966 | +9.0% | 0.24% | -32.2% |
| Q3 2022 | $13,831,000 | +33.6% | 618,267 | 0.0% | 0.36% | +18.6% |
| Q2 2022 | $10,356,000 | -42.5% | 618,267 | +2.8% | 0.30% | -33.6% |
| Q1 2022 | $18,008,000 | -1.9% | 601,667 | +0.7% | 0.45% | +6.8% |
| Q4 2021 | $18,357,000 | +24.0% | 597,767 | +27.3% | 0.42% | +36.3% |
| Q3 2021 | $14,805,000 | -10.1% | 469,560 | +4.3% | 0.31% | -4.6% |
| Q2 2021 | $16,475,000 | +89.0% | 450,258 | +78.6% | 0.33% | +71.6% |
| Q1 2021 | $8,716,000 | -49.1% | 252,127 | -38.8% | 0.19% | -47.7% |
| Q4 2020 | $17,123,000 | -2.8% | 412,000 | -0.4% | 0.36% | -18.8% |
| Q3 2020 | $17,618,000 | – | 413,674 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |